
    
      In this randomized trial, eligible patients who provide written consent for participation
      will be enrolled. At enrollment we will collect baseline demographic data and ask
      participants to complete questionnaires and a 3-day bladder diary. Subjects will be
      randomized in a 1:1 ratio to continence pessary or disposable intravaginal device.
    
  